The groundbreaking therapy of this peptide represents a significant development in the management of type 2 diabetes. Different to existing therapies, tirzepatide targets two pathways – GLP-1 and GIP – providing https://tirzepatidepeptide587910.bloginder.com/42638479/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment